Skip to content

ADVB ADVANCED BIOMED INC

Follow

COM NEW (common), issuer CIK 1941029

Filings received so far for Q3 2026: 8 13F filers report a position in ADVB shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC48,137$300K<0.01%new13F-HRTimelineGroup
GEODE CAPITAL MANAGEMENT, LLCin group GEODE CAPITAL MANAGEMENT, LLC20,170$126K<0.01%new13F-HRTimelineGroup
RENAISSANCE TECHNOLOGIES LLCin group RENAISSANCE TECHNOLOGIES LLC10,500$65.4K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG4,474$27.9K<0.01%new13F-HRTimelineGroup
VALLEY NATIONAL ADVISERS INC1,000$6.23K<0.01%new13F-HRTimeline
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…471$2.93K<0.01%new13F-HRTimelineGroup
Caitong International Asset Management …9$56<0.01%new13F-HRTimeline
JPMORGAN CHASE & COin group JPMORGAN CHASE & CO1$6<0.01%new13F-HRTimelineGroup